Ignite Creation Date:
2024-05-06 @ 9:34 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03011970
Status:
COMPLETED
Last Update Posted:
2017-01-06
First Post:
2016-12-12
Brief Title:
Temporal Dynamics and Pharmacokinetics of Intranasally Administered Oxytocin
Sponsor:
University Hospital Bonn
Organization:
University Hospital Bonn
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether effects of intranasal oxytocin on amygdala response vary as a function of treatment dose and dose-test latency
Detailed Description:
The objective of the present study is to determine whether intranasal oxytocin IN-OXT effects on blood oxygenation level-dependent functional magnetic resonance imaging BOLD fMRI in the amygdala vary as a function of dose and latency In particular the investigators plan to compare effects of three different IN-OXT doses 12 24 and 48 international units IU and three different dose-test latencies of IN-OXT administration task starting at 15 45 and 75min after administration on established neural and behavioural correlates of emotion processing As effects of OXT are particularly promising in autism the investigators further want to investigate how autistic-like traits influence the OXT effects in exploratory post-hoc analyses
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None